FDA to Host Public Meeting on the Scope of Dietary Supplement Ingredients

FDA Announces Public Meeting on Dietary Supplement Ingredient Scope

The U.S. Food and Drug Administration will host a public meeting on March 27, 2026, focused on exploring the scope of dietary supplement ingredients under the Dietary Supplement Health and Education Act (DSHEA).

The meeting will bring together FDA and industry stakeholders to discuss how current regulatory definitions and frameworks apply to evolving ingredient types and innovation within the dietary supplement sector.

Topics for Discussion

FDA has indicated the meeting may address:

• The scope of substances that qualify as dietary ingredients
• Scientific and regulatory considerations for novel ingredients
• Innovation trends and emerging ingredient technologies
• Stakeholder perspectives on current regulatory frameworks

Why This Meeting Is Relevant

As the dietary supplement market continues to evolve, questions around ingredient eligibility and classification have become increasingly important.

This meeting may provide insight into how FDA is evaluating the boundaries of dietary ingredient definitions and how regulatory thinking may develop in response to innovation.

Participation and Information

Additional details, including registration and meeting materials, are available through FDA: https://www.fda.gov/food/workshops-meetings-webinars-food-and-dietary-supplements/public-meeting-exploring-scope-dietary-supplement-ingredients-03272026

EAS Perspective

Public meetings such as this provide an opportunity for FDA to gather stakeholder input and better understand industry perspectives. Companies involved in ingredient development and product innovation may wish to monitor or participate in the discussion.

EAS will continue tracking outcomes from this meeting and provide updates as relevant.